SPC203-20 GENERAL SESSION - Clinical Lab 2.0: Why Lab? Why Now?: The Clinical Lab 2.0 Movement

Course overview

As transition from volume value, what is the significance of lab in value-based healthcare and population heath? How is Clinical Lab 2.0 amplified in the current environment? In this panel we will: Explain the attributes of Clinical Lab 2.0 and how it builds on a strong 1.0 foundation. Discuss the importance Clinical Lab 2.0 Leadership: take an active seat at the table with stakeholders and key partners. Determine Clinical Lab 2.0 Standards: measure what matters to Clinical Lab 2.0 stakeholders: Explore Clinical Lab 2.0 Evidence, how can Clinical Lab 2.0 improve health outcome and optimize financial risk. Consider how the COVID-19 crisis has, or has not, empowered Laboratories to move more effectively in the Clinical Lab 2.0 space.